TreeWAS – Variant ID: rs4703822

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
S61.9 Open wound of wrist and hand, part unspecified	0.027	0.973	0.000
I89.0 Lymphoedema, not elsewhere classified	0.021	0.979	0.000
J93.9 Pneumothorax, unspecified	0.017	0.983	0.000
J06.9 Acute upper respiratory infection, unspecified	0.000	0.986	0.014
J93 Pneumothorax	0.013	0.987	0.000
I89 Other non-infective disorders of lymphatic vessels and lymph nodes	0.013	0.987	0.000
C67.4 Posterior wall of bladder	0.000	0.988	0.012
I89.9 Non-infective disorder of lymphatic vessels and lymph nodes, unspecified	0.012	0.988	0.000
J93.0 Spontaneous tension pneumothorax	0.011	0.989	0.000
J93.1 Other spontaneous pneumothorax	0.011	0.989	0.000
I89.1 Lymphangitis	0.011	0.989	0.000
J93.8 Other pneumothorax	0.010	0.990	0.000
C54.1 Endometrium	0.000	0.992	0.008
U89.8 Agent resistant to other single specified antibiotic	0.000	0.992	0.008
F33.9 Recurrent depressive disorder, unspecified	0.000	0.993	0.007
I89.8 Other specified non-infective disorders of lymphatic vessels and lymph nodes	0.007	0.993	0.000
J06 Acute upper respiratory infections of multiple and unspecified sites	0.000	0.993	0.007
D35.1 Parathyroid gland	0.006	0.994	0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.000	0.994	0.006
F33 Recurrent depressive disorder	0.000	0.994	0.006
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.000	0.994	0.006
U89 Agent resistant to other and unspecified antibiotics	0.000	0.994	0.006
J03.9 Acute tonsillitis, unspecified	0.000	0.995	0.005
J06.8 Other acute upper respiratory infections of multiple sites	0.000	0.995	0.005
Z88.7 Personal history of allergy to serum and vaccine	0.000	0.995	0.005
Z88.2 Personal history of allergy to sulphonamides	0.000	0.995	0.005
C67 Malignant neoplasm of bladder	0.000	0.995	0.005
F33.1 Recurrent depressive disorder, current episode moderate	0.000	0.995	0.005
S89.9 Unspecified injury of lower leg	0.000	0.995	0.005
F33.0 Recurrent depressive disorder, current episode mild	0.000	0.995	0.005
D16.1 Short bones of upper limb	0.000	0.995	0.005
F33.8 Other recurrent depressive disorders	0.000	0.996	0.004
F33.4 Recurrent depressive disorder, currently in remission	0.000	0.996	0.004
C54 Malignant neoplasm of corpus uteri	0.000	0.996	0.004
C67.6 Ureteric orifice	0.000	0.996	0.004
U89.9 Agent resistant to unspecified antibiotic	0.000	0.996	0.004
J06.0 Acute laryngopharyngitis	0.000	0.996	0.004
Y49.2 Other and unspecified antidepressants	0.004	0.996	0.000
C67.3 Anterior wall of bladder	0.000	0.996	0.004
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.000	0.996	0.004
C67.0 Trigone of bladder	0.000	0.996	0.004
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.000	0.996	0.004
I70.2 Atherosclerosis of arteries of the extremities	0.000	0.996	0.004
J03 Acute tonsillitis	0.000	0.996	0.004
C54.9 Corpus uteri, unspecified	0.000	0.996	0.004
C67.1 Dome of bladder	0.000	0.996	0.004
C67.7 Urachus	0.000	0.996	0.004
Y53.4 Other laxatives	0.004	0.996	0.000
N88.2 Stricture and stenosis of cervix uteri	0.000	0.996	0.004
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.000	0.996	0.003
F31.0 Bipolar affective disorder, current episode hypomanic	0.000	0.996	0.004
U80.0 Penicillin resistant agent	0.000	0.996	0.004
U88 Agent resistant to multiple antibiotics	0.000	0.996	0.003
C54.8 Overlapping lesion of corpus uteri	0.000	0.997	0.003
C54.3 Fundus uteri	0.000	0.997	0.003
C54.2 Myometrium	0.000	0.997	0.003
C54.0 Isthmus uteri	0.000	0.997	0.003
Y53 Agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
U84 Resistance to other antimicrobial drugs	0.000	0.997	0.003
U83 Resistance to other antibiotics	0.000	0.997	0.003
U82 Resistance to betalactam antibiotics	0.000	0.997	0.003
U85 Resistance to antineoplastic drugs	0.000	0.997	0.003
C92.1 Chronic myeloid leukaemia	0.003	0.997	0.000
J03.8 Acute tonsillitis due to other specified organisms	0.000	0.997	0.003
J03.0 Streptococcal tonsillitis	0.000	0.997	0.003
C67.2 Lateral wall of bladder	0.000	0.997	0.003
J00-J06 Acute upper respiratory infections	0.000	0.997	0.003
F31 Bipolar affective disorder	0.000	0.997	0.003
I70.21 Atherosclerosis of arteries of extremities (with gangrene)	0.000	0.997	0.003
S30.8 Other superficial injuries of abdomen, lower back and pelvis	0.000	0.997	0.003
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.997	0.000
J04.0 Acute laryngitis	0.000	0.997	0.003
Z54.0 Convalescence following surgery	0.003	0.997	0.000
J04 Acute laryngitis and tracheitis	0.000	0.997	0.003
Y44 Agents primarily affecting blood constituents	0.003	0.997	0.000
Y44.2 Anticoagulants	0.003	0.997	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.003	0.997	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
C67.9 Bladder, unspecified	0.000	0.997	0.003
Y47 Sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y44.5 Thrombolytic drugs	0.003	0.997	0.000
C67.8 Overlapping lesion of bladder	0.000	0.997	0.002
K92.9 Disease of digestive system, unspecified	0.003	0.997	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y53.7 Emetics	0.003	0.997	0.000
Y53.6 Antidiarrhoeal drugs	0.003	0.997	0.000
Y53.5 Digestants	0.003	0.997	0.000
Y53.3 Saline and osmotic laxatives	0.003	0.997	0.000
Y53.2 Stimulant laxatives	0.003	0.997	0.000
Y53.0 Histamine H2-receptor antagonists	0.003	0.997	0.000
S89 Other and unspecified injuries of lower leg	0.000	0.997	0.003
Y46 Antiepileptics and anti-Parkinsonism drugs	0.003	0.997	0.000
C67.5 Bladder neck	0.000	0.997	0.003
Y47.1 Benzodiazepines	0.003	0.997	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.003	0.997	0.000
Y41.5 Antiviral drugs	0.003	0.997	0.000
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.000	0.997	0.003
Y54.3 Benzothiadiazine derivatives	0.003	0.997	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.003	0.997	0.000
Z84.2 Family history of other diseases of the genito-urinary system	0.003	0.997	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.003	0.997	0.000
U80 Agent resistant to penicillin and related antibiotics	0.000	0.997	0.003
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
Y49.9 Psychotropic drug, unspecified	0.002	0.997	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.002	0.997	0.000
Y49.7 Psychostimulants with abuse potential	0.002	0.997	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.002	0.997	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.997	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.997	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.997	0.000
U82.9 Resistance to betalactam antibiotics, unspecified	0.000	0.997	0.002
U82.8 Resistance to other betalactam antibiotics	0.000	0.997	0.002
U82.2 Extended spectrum betalactamase (ESBL) resistance	0.000	0.997	0.002
U82.1 Resistance to methicillin	0.000	0.997	0.002
U82.0 Resistance to penicillin	0.000	0.997	0.002
U83.9 Resistance to unspecified antibiotic	0.000	0.997	0.002
U83.8 Resistance to other single specified antibiotic	0.000	0.997	0.002
U83.7 Resistance to multiple antibiotics	0.000	0.997	0.002
U83.2 Resistance to quinolones	0.000	0.997	0.002
U83.1 Resistance to other vancomycin related antibiotics	0.000	0.997	0.002
U83.0 Resistance to vancomycin	0.000	0.997	0.002
U84.9 Resistance to unspecified antimicrobial drugs	0.000	0.997	0.002
U84.8 Resistance to other specified antimicrobial drug	0.000	0.997	0.002
U84.7 Resistance to multiple antimicrobial drugs	0.000	0.997	0.002
U84.3 Resistance to tuberculostatic drug(s)	0.000	0.997	0.002
U84.2 Resistance to antiviral drug(s)	0.000	0.997	0.002
U84.1 Resistance to antifungal drug(s)	0.000	0.997	0.002
U84.0 Resistance to antiparasitic drug(s)	0.000	0.997	0.002
Y44.6 Natural blood and blood products	0.002	0.997	0.000
I70 Atherosclerosis	0.000	0.997	0.003
Y54.8 Agents affecting uric acid metabolism	0.003	0.997	0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.000	0.997	0.003
I70.10 Atherosclerosis of renal artery (without gangrene)	0.000	0.997	0.002
Chapter XXII Codes for special purposes	0.000	0.997	0.003
I70.1 Atherosclerosis of renal artery	0.000	0.997	0.002
S89.8 Other specified injuries of lower leg	0.000	0.997	0.002
Y58 Bacterial vaccines	0.002	0.997	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.000	0.997	0.002
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.997	0.000
F31.8 Other bipolar affective disorders	0.000	0.998	0.002
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
J01 Acute sinusitis	0.000	0.998	0.002
R01.1 Cardiac murmur, unspecified	0.000	0.998	0.002
J04.2 Acute laryngotracheitis	0.000	0.998	0.002
J04.1 Acute tracheitis	0.000	0.998	0.002
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y52 Agents primarily affecting the cardiovascular system	0.002	0.998	0.000
O75.8 Other specified complications of labour and delivery	0.002	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
F31.7 Bipolar affective disorder, currently in remission	0.000	0.998	0.002
U51.1 Previously admitted to a psychiatric hospital of the provider	0.000	0.998	0.002
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
F32.1 Moderate depressive episode	0.000	0.998	0.002
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y57 Other and unspecified drugs and medicaments	0.002	0.998	0.000
I80.0 Phlebitis and thrombophlebitis of superficial vessels of lower extremities	0.002	0.998	0.000
X41.9 Unspecified place	0.000	0.998	0.002
Y46.4 Iminostilbenes	0.002	0.998	0.000
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
D23.6 Skin of upper limb, including shoulder	0.000	0.998	0.002
Z03.9 Observation for suspected disease or condition, unspecified	0.000	0.998	0.002
U51 Admission status on psychiatric patients	0.000	0.998	0.002
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.998	0.000
Y47.4 Bromine compounds	0.002	0.998	0.000
Y47.3 Paraldehyde	0.002	0.998	0.000
Y47.2 Chloral derivatives	0.002	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
Y57.5 X-ray contrast media	0.002	0.998	0.000
R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems	0.000	0.998	0.002
H27.0 Aphakia	0.000	0.998	0.002
J01.9 Acute sinusitis, unspecified	0.000	0.998	0.002
Y54.7 Agents affecting calcification	0.002	0.998	0.000
Z84.8 Family history of other specified conditions	0.002	0.998	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.002	0.998	0.000
F31.6 Bipolar affective disorder, current episode mixed	0.000	0.998	0.002
S89.7 Multiple injuries of lower leg	0.000	0.998	0.002
S89.1 Other specified injuries of lower leg	0.000	0.998	0.002
S89.0 Multiple injuries of lower leg	0.000	0.998	0.002
Y46.8 Antispasticity drugs	0.002	0.998	0.000
Y46.5 Valproic acid	0.002	0.998	0.000
Y46.3 Deoxybarbiturates	0.002	0.998	0.000
Y46.1 Oxazolidinediones	0.002	0.998	0.000
Y46.0 Succinimides	0.002	0.998	0.000
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.000	0.998	0.002
Y45.4 Antirheumatics	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
I70.0 Atherosclerosis of aorta	0.000	0.998	0.002
I70.9 Generalised and unspecified atherosclerosis	0.000	0.998	0.002
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.002	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.998	0.000
Y54.0 Mineralocorticoids	0.002	0.998	0.000
Y57.6 Other diagnostic agents	0.002	0.998	0.000
Y58.0 BCG vaccine	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
Y41.1 Antimycobacterial drugs	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
Z54.4 Convalescence following treatment of fracture	0.002	0.998	0.000
I70.8 Atherosclerosis of other arteries	0.000	0.998	0.002
U50 Level of care administered to neonates	0.000	0.998	0.002
U07 Emergency use of U07	0.000	0.998	0.002
U06 Emergency use of U06	0.000	0.998	0.002
U04 Severe acute respiratory syndrome [SARS]	0.000	0.998	0.002
U52 First in a series of a regular day/night admissions	0.000	0.998	0.002
Y42.1 Thyroid hormones and substitutes	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
C92.9 Myeloid leukaemia, unspecified	0.002	0.998	0.000
J01.0 Acute maxillary sinusitis	0.000	0.998	0.002
U80.8 Agent resistant to other penicillin-related antibiotic	0.000	0.998	0.002
F30-F39 Mood [affective] disorders	0.000	0.998	0.002
I70.11 Atherosclerosis of renal artery (with gangrene)	0.000	0.998	0.002
J01.8 Other acute sinusitis	0.000	0.998	0.002
Y46.7 Anti-Parkinsonism drugs	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
H47.3 Other disorders of optic disk	0.000	0.998	0.002
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
J05 Acute obstructive laryngitis [croup] and epiglottitis	0.000	0.998	0.002
Z84 Family history of other conditions	0.002	0.998	0.000
G11.9 Hereditary ataxia, unspecified	0.000	0.998	0.002
C92 Myeloid leukaemia	0.002	0.998	0.000
H47.0 Disorders of optic nerve, not elsewhere classified	0.000	0.998	0.002
J01.3 Acute sphenoidal sinusitis	0.000	0.998	0.002
J01.1 Acute frontal sinusitis	0.000	0.998	0.002
Y41.0 Sulphonamides	0.002	0.998	0.000
Y45.5 4-Aminophenol derivatives	0.002	0.998	0.000
Z54 Convalescence	0.002	0.998	0.000
M85.00 Fibrous dysplasia (monostotic) (Multiple sites)	0.002	0.998	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
Y45.8 Other analgesics and antipyretics	0.002	0.998	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.998	0.000
C92.0 Acute myeloid leukaemia	0.002	0.998	0.000
Y50.9 Central nervous system stimulant, unspecified	0.002	0.998	0.000
Y50.8 Other central nervous system stimulants	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.998	0.000
Y50.1 Opioid receptor antagonists	0.002	0.998	0.000
Y50.0 Analeptics	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
N05.9 Unspecified	0.000	0.998	0.002
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
D07.1 Vulva	0.002	0.998	0.000
Y42.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
Y42.4 Oral contraceptives	0.002	0.998	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
Z84.0 Family history of diseases of the skin and subcutaneous tissue	0.002	0.998	0.000
U81 Agent resistant to vancomycin and related antibiotics	0.000	0.998	0.002
Y45.1 Salicylates	0.002	0.998	0.000
Y57.7 Vitamins, not elsewhere classified	0.002	0.998	0.000
Y57.4 Pharmaceutical excipients	0.002	0.998	0.000
Y57.3 Alcohol deterrents	0.002	0.998	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
Y57.1 Lipotropic drugs	0.002	0.998	0.000
Y57.0 Appetite depressants [anorectics]	0.002	0.998	0.000
U51.2 Previously admitted to a psychiatric hospital of another provider	0.000	0.998	0.002
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
I70.00 Atherosclerosis of aorta (without gangrene)	0.000	0.998	0.002
J01.2 Acute ethmoidal sinusitis	0.000	0.998	0.002
Y42.0 Glucocorticoids and synthetic analogs	0.002	0.998	0.000
D22.4 Melanocytic naevi of scalp and neck	0.000	0.998	0.002
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.000	0.998	0.002
Y45.2 Propionic acid derivatives	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.002	0.998	0.000
Y56.8 Other topical agents	0.002	0.998	0.000
Y56.7 Dental drugs, topically applied	0.002	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
Y56.2 Local astringents and local detergents	0.002	0.998	0.000
Y56.1 Antipruritics	0.002	0.998	0.000
I70.90 Generalized and unspecified atherosclerosis (without gangrene)	0.000	0.998	0.002
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
Y51.0 Anticholinesterase agents	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
I70.01 Atherosclerosis of aorta (with gangrene)	0.000	0.998	0.002
D25.0 Submucous leiomyoma of uterus	0.000	0.998	0.002
H47.2 Optic atrophy	0.000	0.998	0.002
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
Z84.1 Family history of disorders of the kidney and ureter	0.002	0.998	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Z54.8 Convalescence following other treatment	0.002	0.998	0.000
I70.91 Generalized and unspecified atherosclerosis (with gangrene)	0.000	0.998	0.002
O66.5 Failed application of vacuum extractor and forceps, unspecified	0.000	0.998	0.002
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.000	0.998	0.002
I70.81 Atherosclerosis of other arteries (with gangrene)	0.000	0.998	0.002
I70.80 Atherosclerosis of other arteries (without gangrene)	0.000	0.998	0.002
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.000	0.998	0.002
U06.9 Emergency use of U06.9	0.000	0.998	0.002
U06.8 Emergency use of U06.8	0.000	0.998	0.002
U06.7 Emergency use of U06.7	0.000	0.998	0.002
U06.6 Emergency use of U06.6	0.000	0.998	0.002
U06.5 Emergency use of U06.5	0.000	0.998	0.002
U06.4 Emergency use of U06.4	0.000	0.998	0.002
U06.3 Emergency use of U06.3	0.000	0.998	0.002
U06.2 Emergency use of U06.2	0.000	0.998	0.002
U06.1 Emergency use of U06.1	0.000	0.998	0.002
U06.0 Emergency use of U06.0	0.000	0.998	0.002
U07.9 Emergency use of U07.9	0.000	0.998	0.002
U07.8 Emergency use of U07.8	0.000	0.998	0.002
U07.7 Emergency use of U07.7	0.000	0.998	0.002
U07.6 Emergency use of U07.6	0.000	0.998	0.002
U07.5 Emergency use of U07.5	0.000	0.998	0.002
U07.4 Emergency use of U07.4	0.000	0.998	0.002
U07.3 Emergency use of U07.3	0.000	0.998	0.002
U07.2 Emergency use of U07.2	0.000	0.998	0.002
U07.1 Emergency use of U07.1	0.000	0.998	0.002
U07.0 Emergency use of U07.0	0.000	0.998	0.002
U50.9 Inquest Adjourned Death	0.000	0.998	0.002
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.000	0.998	0.002
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.000	0.998	0.002
U50.1 Level of care administered to neonates (Special Care)	0.000	0.998	0.002
U50.0 Level of care administered to neonates (Normal Care)	0.000	0.998	0.002
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.998	0.000
F38 Other mood [affective] disorders	0.000	0.998	0.002
H47 Other disorders of optic [2nd] nerve and visual pathways	0.000	0.998	0.002
G57.6 Lesion of plantar nerve	0.000	0.998	0.002
J01.4 Acute pansinusitis	0.000	0.998	0.001
Z84.3 Family history of consanguinity	0.002	0.998	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.002	0.998	0.000
C92.7 Other myeloid leukaemia	0.002	0.998	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.002	0.998	0.000
C92.5 Acute myelomonocytic leukaemia	0.002	0.998	0.000
C92.3 Myeloid sarcoma	0.002	0.998	0.000
C92.2 Subacute myeloid leukaemia	0.002	0.998	0.000
J05.0 Acute obstructive laryngitis [croup]	0.000	0.998	0.001
Y54.4 Loop [high-ceiling] diuretics	0.001	0.998	0.000
T83.3 Mechanical complication of intra-uterine contraceptive device	0.000	0.998	0.002
Z54.9 Convalescence following unspecified treatment	0.002	0.998	0.000
Z54.7 Convalescence following combined treatment	0.002	0.998	0.000
Z54.3 Convalescence following psychotherapy	0.002	0.998	0.000
Z54.2 Convalescence following chemotherapy	0.002	0.998	0.000
Z54.1 Convalescence following radiotherapy	0.002	0.998	0.000
Y42.2 Antithyroid drugs	0.002	0.998	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.001	0.998	0.000
Y59.3 Immunoglobulin	0.001	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
Y54.5 Other diuretics	0.001	0.998	0.000
O73.0 Retained placenta, without haemorrhage	0.002	0.998	0.000
U81.8 Agent resistant to other vancomycin-related antibiotic	0.000	0.998	0.001
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.001	0.998	0.000
Z52.4 Kidney donor	0.002	0.998	0.000
B95.6 Staphylococcus aureus as the cause of diseases classified to other chapters	0.000	0.998	0.002
C64-C68 Malignant neoplasms of urinary tract	0.000	0.998	0.002
F02.0 Dementia in Pick's disease	0.000	0.998	0.002
F31.9 Bipolar affective disorder, unspecified	0.000	0.998	0.002
F81.9 Developmental disorder of scholastic skills, unspecified	0.000	0.998	0.002
L43.9 Lichen planus, unspecified	0.000	0.998	0.002
Y57.8 Other drugs and medicaments	0.001	0.998	0.000
C65 Malignant neoplasm of renal pelvis	0.000	0.998	0.002
F34 Persistent mood [affective] disorders	0.000	0.998	0.002
Y45.0 Opioids and related analgesics	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.001	0.998	0.000
K05.6 Periodontal disease, unspecified	0.000	0.998	0.002
Y42.7 Androgens and anabolic congeners	0.002	0.998	0.000
M79.09 Rheumatism, unspecified (Site unspecified)	0.002	0.998	0.000
F38.8 Other specified mood [affective] disorders	0.000	0.998	0.001
F38.1 Other recurrent mood [affective] disorders	0.000	0.998	0.001
F38.0 Other single mood [affective] disorders	0.000	0.998	0.001
H47.7 Disorder of visual pathways, unspecified	0.000	0.998	0.001
H47.6 Disorders of visual cortex	0.000	0.998	0.001
H47.5 Disorders of other visual pathways	0.000	0.998	0.001
H47.4 Disorders of optic chiasm	0.000	0.998	0.001
N90.9 Noninflammatory disorder of vulva and perineum, unspecified	0.002	0.998	0.000
U51.0 Not Previously admitted to a psyciatric hospital	0.000	0.998	0.001
N88.1 Old laceration of cervix uteri	0.000	0.998	0.001
R00.8 Other and unspecified abnormalities of heart beat	0.002	0.998	0.000
R26.0 Ataxic gait	0.002	0.998	0.000
K38.8 Other specified diseases of appendix	0.000	0.998	0.002
M65.91 Synovitis and tenosynovitis, unspecified (Shoulder region)	0.000	0.998	0.001
C92.4 Acute promyelocytic leukaemia	0.001	0.998	0.000
F22.0 Delusional disorder	0.001	0.999	0.000
G80.9 Infantile cerebral palsy, unspecified	0.001	0.999	0.000
U81.0 Vancomycin resistant agent	0.000	0.999	0.001
F39 Unspecified mood [affective] disorder	0.000	0.999	0.001
Y86 Sequelae of other accidents	0.000	0.999	0.001
F34.9 Persistent mood [affective] disorder, unspecified	0.000	0.999	0.001
F34.8 Other persistent mood [affective] disorders	0.000	0.999	0.001
T24.2 Burn of second degree of hip and lower limb, except ankle and foot	0.001	0.999	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.001	0.999	0.000
J90-J94 Other diseases of pleura	0.001	0.999	0.000
H21.5 Other adhesions and disruptions of iris and ciliary body	0.001	0.999	0.000
H60.8 Other otitis externa	0.001	0.999	0.000
D16.2 Long bones of lower limb	0.000	0.999	0.001
Y52.4 Angiotensin-converting-enzyme inhibitors	0.001	0.999	0.000
S22.00 Fracture of thoracic vertebra (closed)	0.000	0.999	0.001
W49.9 Unspecified place	0.000	0.999	0.001
C68 Malignant neoplasm of other and unspecified urinary organs	0.000	0.999	0.001
D44.7 Aortic body and other paraganglia	0.001	0.999	0.000
F34.0 Cyclothymia	0.000	0.999	0.001
H58.8 Visual disturbances in diseases classified elsewhere	0.001	0.999	0.000
I77.8 Other specified disorders of arteries and arterioles	0.000	0.999	0.001
M85.0 Fibrous dysplasia (monostotic)	0.001	0.999	0.000
Q39.4 Oesophageal web	0.000	0.999	0.001
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb	0.000	0.999	0.001
Y60.4 During endoscopic examination	0.000	0.999	0.001
J02 Acute pharyngitis	0.000	0.999	0.001
V19.3 Pedal cyclist [any] injured in an unspecified nontraffic accident	0.001	0.999	0.000
Y65.4 Failure to introduce or to remove other tube or instrument	0.000	0.999	0.001
F34.1 Dysthymia	0.000	0.999	0.001
J94.8 Other specified pleural conditions	0.001	0.999	0.000
O66.0 Obstructed labour due to shoulder dystocia	0.000	0.999	0.001
Z43.3 Attention to colostomy	0.001	0.999	0.000
N88 Other noninflammatory disorders of cervix uteri	0.000	0.999	0.001
G11.4 Hereditary spastic paraplegia	0.000	0.999	0.001
H60.1 Cellulitis of external ear	0.001	0.999	0.000
H66.3 Other chronic suppurative otitis media	0.001	0.999	0.000
J05.1 Acute epiglottitis	0.000	0.999	0.001
K05.1 Chronic gingivitis	0.000	0.999	0.001
R01.0 Benign and innocent cardiac murmurs	0.000	0.999	0.001
R01 Cardiac murmurs and other cardiac sounds	0.000	0.999	0.001
H47.1 Papilloedema, unspecified	0.000	0.999	0.001
G11 Hereditary ataxia	0.000	0.999	0.001
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.000	0.999	0.001
I12.9 Hypertensive renal disease without renal failure	0.000	0.999	0.001
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene	0.001	0.999	0.000
T92.9 Sequelae of unspecified injury of upper limb	0.000	0.999	0.001
V19.8 Pedal cyclist [any] injured in other specified transport accidents	0.001	0.999	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.001	0.999	0.000
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.000	0.999	0.001
K51.9 Ulcerative colitis, unspecified	0.001	0.999	0.000
K70.4 Alcoholic hepatic failure	0.001	0.999	0.000
Q51.3 Bicornate uterus	0.000	0.999	0.001
Y42.5 Other oestrogens and progestogens	0.001	0.999	0.000
M85.09 Fibrous dysplasia (monostotic) (Site unspecified)	0.001	0.999	0.000
M85.08 Fibrous dysplasia (monostotic) (Other)	0.001	0.999	0.000
M85.07 Fibrous dysplasia (monostotic) (Ankle and foot)	0.001	0.999	0.000
M85.06 Fibrous dysplasia (monostotic) (Lower leg)	0.001	0.999	0.000
M85.05 Fibrous dysplasia (monostotic) (Pelvic region and thigh)	0.001	0.999	0.000
M85.04 Fibrous dysplasia (monostotic) (Hand)	0.001	0.999	0.000
M85.03 Fibrous dysplasia (monostotic) (Forearm)	0.001	0.999	0.000
M85.02 Fibrous dysplasia (monostotic) (Upper arm)	0.001	0.999	0.000
M85.01 Fibrous dysplasia (monostotic) (Shoulder region)	0.001	0.999	0.000
C68.8 Overlapping lesion of urinary organs	0.000	0.999	0.001
C68.1 Paraurethral glands	0.000	0.999	0.001
T93.5 Sequelae of injury of muscle and tendon of lower limb	0.000	0.999	0.001
W44.0 Home	0.000	0.999	0.001
Y57.9 Drug or medicament, unspecified	0.001	0.999	0.000
G31.0 Circumscribed brain atrophy	0.000	0.999	0.001
H93.1 Tinnitus	0.000	0.999	0.001
J02.8 Acute pharyngitis due to other specified organisms	0.000	0.999	0.001
N42.9 Disorder of prostate, unspecified	0.000	0.999	0.001
Z46.8 Fitting and adjustment of other specified devices	0.000	0.999	0.001
C66 Malignant neoplasm of ureter	0.000	0.999	0.001
N88.4 Hypertrophic elongation of cervix uteri	0.000	0.999	0.001
N88.3 Incompetence of cervix uteri	0.000	0.999	0.001
N88.0 Leukoplakia of cervix uteri	0.000	0.999	0.001
R01.2 Other cardiac sounds	0.000	0.999	0.001
Z34.8 Supervision of other normal pregnancy	0.001	0.999	0.000
M43.02 Spondylolysis (Cervical region)	0.001	0.999	0.000
M85.86 Other specified disorders of bone density and structure (Lower leg)	0.001	0.999	0.000
C68.9 Urinary organ, unspecified	0.000	0.999	0.001
C68.0 Urethra	0.000	0.999	0.001
D44.1 Adrenal gland	0.001	0.999	0.000
G11.8 Other hereditary ataxias	0.000	0.999	0.001
G11.3 Cerebellar ataxia with defective DNA repair	0.000	0.999	0.001
G11.2 Late-onset cerebellar ataxia	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations